OKLO Q2 FY2026 earnings call — BigGo Finance
Oklo Inc. reported a first-half 2026 net loss of $81.6 million, with operating loss of $124.2 million offset by $44.5 million of net interest and dividend income, and no revenue recognized. Cash and marketable securities were $3.0 billion at June 30, 2026. Management raised FY2026 operating cash use to $120 million-$150 million and capex to $400 million-$500 million. Key updates include Groves first criticality and DOE progress for Aurora-INL.
How this was made
The 30-second read
Why it matters
The call updates FY2026 cash and capex guidance upward, confirms Groves reached first criticality, and provides progress markers for Aurora-INL (DOE PDSA approval) and Aurora Ohio (Kiewit MOU for a 1.2 GW campus serving Meta).
Market read
Traders get fresh, time-sensitive guidance ranges and a major execution milestone, but must weigh continued pre-revenue status and non-binding/DOE-dependent fuel and isotope commercialization timelines.
What to watch
The Centrus HALEU and plutonium bridge-fuel items are described as LOI and advanced negotiations, so the market may over-discount execution risk if it treats them as definitive supply contracts.
Background
Oklo is a pre-commercial advanced nuclear developer building integrated power (Aurora), fuel (HALEU and fabrication), and isotopes (Groves and radiochemistry).
Ticker impact
Oklo raised FY2026 operating cash use to $120M-$150M and capex to $400M-$500M, citing accelerated Aurora-INL procurement and grid interconnection spending.
Bias modestly positive on the guidance upgrade and Groves milestone, with volatility tied to DOE approvals and 2027-2028 startup timing.
The article provides fresh, decision-relevant numbers (cash use and capex ranges) plus a concrete operational event (Groves first criticality) and updated DOE/LOI timelines, which can re-rate execution probability. However, revenue remains zero and several catalysts depend on DOE/NRC approvals and non-binding agreements, limiting conviction.
Market effects
Reinforces the US advanced nuclear development narrative, with emphasis on integrated power-fuel-isotopes execution and HALEU supply pathways.
US-focused nuclear infrastructure and isotope commercialization timelines, with potential knock-on attention to DOE/NRC process throughput.
Limited direct global read-through, but supports broader investor sentiment toward next-gen nuclear supply chains and fuel-cycle capability.
Counterpoint
Upward cash-use and capex guidance could signal cost pressure and schedule risk, especially with first-of-a-kind expensed project costs and DOE-controlled plutonium allocation timing.
Key entities
- companyOklo Inc.
Reported first-half 2026 net loss, updated FY2026 cash use and capex guidance, and highlighted Groves first criticality plus DOE/NRC progress.
- counterpartyCentrus Energy
Discussed in the context of a HALEU supply letter of intent and advanced negotiations for plutonium bridge fuel.
- counterpartyKiewit
Named in an MOU for EPC and execution planning for Oklo’s 1.2 GW Aurora Ohio campus serving Meta.
- customerMeta
Referenced as the intended initial power customer for the Aurora Ohio clean energy campus.
- regulatorDOE
Approved PDSA for Aurora-INL and selected Oklo for advanced negotiations on surplus plutonium.
